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MAP Kinase Phosphatase-2 Plays a Key Role in the
Control of Infection with Toxoplasma gondii by
Modulating iNOS and Arginase-1 Activities in Mice
Stuart Woods, Juliane Schroeder, Helen A. McGachy, Robin Plevin, Craig W. Roberts, James Alexander*
Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom
Abstract
The dual specific phosphatase, MAP kinase phosphatase-2 (MKP-2) has recently been demonstrated to negatively regulate
macrophage arginase-1 expression, while at the same time to positively regulate iNOS expression. Consequently, MKP-2 is
likely to play a significant role in the host interplay with intracellular pathogens. Here we demonstrate that MKP-22/2 mice
on the C57BL/6 background have enhanced susceptibility compared with wild-type counterparts following infection with
type-2 strains of Toxoplasma gondii as measured by increased parasite multiplication during acute infection, increased
mortality from day 12 post-infection onwards and increased parasite burdens in the brain, day 30 post-infection. MKP-22/2
mice did not, however, demonstrate defective type-1 responses compared with MKP-2+/+ mice following infection although
they did display significantly reduced serum nitrite levels and enhanced tissue arginase-1 expression. Early resistance to T.
gondii in MKP-2+/+, but not MKP-22/2, mice was nitric oxide (NO) dependent as infected MKP-2+/+, but not MKP-22/2 mice
succumbed within 10 days post-infection with increased parasite burdens following treatment with the iNOS inhibitor L-
NAME. Conversely, treatment of infected MKP-22/2 but not MKP-2+/+ mice with nor-NOHA increased parasite burdens
indicating a protective role for arginase-1 in MKP-22/2mice. In vitro studies using tachyzoite-infected bone marrow derived
macrophages and selective inhibition of arginase-1 and iNOS activities confirmed that both iNOS and arginase-1
contributed to inhibiting parasite replication. However, the effects of arginase-1 were transient and ultimately the role of
iNOS was paramount in facilitating long-term inhibition of parasite multiplication within macrophages.
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Introduction
Toxoplasma gondii is an obligate intracellular protozoan parasite
of significant public health importance, being a major cause of
congenital infection and abortion as well as a significant and often
fatal infection in immune compromised hosts. The early acute
stage of infection is characterized by widespread tachyzoite
dissemination and tissue damage. The rapid onset of immunity,
initiated in large part by the well characterized T. gondii pathogen
associated molecular patterns (PAMPS) controls parasite replica-
tion [1–4], and results in the life-long chronic stage of infection
associated with encystment of the parasites in skeletal muscle and
the central nervous system [reviewed in 5]. Protection against
acute disease is mediated primarily by the interaction of
neutrophils, dendritic cells, macrophages and natural killer (NK)
cells that as part of the innate response not only limits parasite
growth, but initiates an effective cytotoxic CD8+ T cell response
that is responsible for long-term protection and prevention of
encephalitis via IFN-c production [6–9]. The mechanisms by
which IFN-c, the major effector cytokine mediating resistance
during T. gondii infection, promotes anti-toxoplasma activity are not
yet fully clear and vary between host species studied. Several IFN-
c-regulated genes including iNOS [6,10], indoleamine 2,3
dioxygenase (IDO) [11,12], and more recently, p47 GTPases,
have been implicated in playing significant roles in mediating these
protective responses [13–21].
Despite being essential to control parasite replication, an
overactive type-1 response and overproduction of IFN-c, TNF-a
and NO can result in severe pathology and death. Consequently,
protective immunity to T. gondii that needs to effectively control
parasite proliferation without excessive inflammation is dependent
on the regulation of type-1 responses by Th2 cells and Treg cells
[22–29]. An overactive type-2 response could equally promote
enhanced parasite proliferation and host death and indeed
alternative macrophage activation has been shown to promote
parasite growth [30]. Interestingly, the classic hallmark indicator
of alternative macrophage activation, arginase-1, can be induced
innately by T. gondii apparently via both STAT-6 dependent [30–
32] and independent mechanisms [30,33]. Paradoxically, argi-
nase-1 has been associated with enhancing infection with T. gondii
by competing with iNOS for their common substrate L-arginine
[33] and promoting parasite replication by providing the
polyamines needed for cell division [32]. Conversely arginase-1
might also limit parasite growth by starving the parasite of the L-
arginine it requires for this process [31,34].
A recent study has demonstrated that the dual specific
phosphatase, MKP-2 is not only a negative regulator of
macrophage arginase-1 but also a positive regulator of iNOS
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expression [35]. Furthermore MKP-22/2 C57BL/6 mice have
been found to display enhanced susceptibility to the intracellular
parasite Leishmania mexicana. Susceptibility in MKP-22/2 mice was
in large part due to enhanced parasite growth that could be
reversed by inhibiting arginase-1 activity. Given the importance of
NO production as well as the apparently contradictory roles of
arginase-1 in murine T. gondii infections it is likely that the role of
MKP-2 in T. gondii infection would be one of major significance.
We consequently studied the course of T. gondii infection in MKP-
22/2 and MKP-2+/+ C57BL/6 mice. We identified that MKP-2
deficiency results in increased susceptibility to T. gondii infection
and that this correlated strongly with impaired iNOS activity in
vivo. Conversely we demonstrated an arginase-1 dependent
mechanism responsible for control of parasite growth that
functioned to partially protect the host independently of iNOS
mediated effects.
Materials and Methods
Ethics statement
All animal procedures conformed to guidelines from The Home
Office of the UK Government. All work was covered by two
Home Office licences: PPL60/3929, ‘‘mechanism of control of
parasite infection’’ and PPL60/3439,‘‘genetic models of cancer
and inflammation’’ with approval by the University of Strathclyde
ethical review panel.
Mice
MKP-2+/+ and MKP-22/2 mice on a C57BL/6 background
were bred and maintained and all experiments carried out in
house at the Strathclyde Institute of Pharmacy and Biomedical
Sciences, Glasgow, UK. Six to eight week old, male mice were
used for infection and aged matched within each experiment.
Maintenance and infection of Toxoplasma gondii Beverly
strain
Beverley cysts were maintained in vivo by intraperitoneal (i.p.)
passage of infective brain tissue homogenates through outbred
CD1 albino mice. For experimental infections MKP-2+/+ and
MKP-22/2 mice were infected i.p. with 10 tissue cysts in 200 ml
sterile PBS.
Maintenance of transfected Toxoplasma gondii
Prugniaud strains
Tachyzoites were routinely maintained in confluent human
foreskin fibroblasts (HFFs) grown in DMEM complete medium
comprising; Dulbecco’s Modified Eagle Medium (DMEM) con-
taining L-glutamine (Invitrogen, UK), 10% foetal calf serum (PAA,
UK), 100 U/ml penicillin (Cambrex Bioscience, Veniers, Bel-
gium), 100 mg/ml streptomycin (Cambrex Bioscience, Veniers,
Belgium) and 50 U/ml amphotericin B (Cambrex Bioscience,
Veniers, Belgium) at 37uC in 5% CO2.
Bioluminescent imaging
In vivo parasite burden was assessed using bioluminescent
imaging using type II Prugniaud T. gondii transfected with the
firefly luciferase [36]. The light data was quantified using Living
Image software (Caliper Life Science)
Briefly, intracellular FLUC T. gondii was harvested from in vitro
culture. Culture media was removed and the HFF monolayer
washed once with sterile PBS (Lonza, UK) prior to disruption with
a cell scraper and harvesting in 10 ml sterile PBS. The
intracellular parasites were then released from the host cells by
passage through a 21 gauge needle and centrifuged at 1200 rpm
for 10 minutes. The bioluminescent activity of the FLUC T. gondii
was quality controlled for each experiment prior to infection using
a standard curve in a black-walled 24 well plate by in vitro imaging
using the IVIS Spectrum (Caliper Life Sciences) (Figure S1). Mice
were then infected with 20,000 tachyzoites i.p. in a volume of
400 ml sterile PBS. FLUC T. gondii infected mice were imaged
using the IVIS Spectrum (Caliper Life Sciences) to determine
parasite burden. Mice to be imaged were given 150 mg/kg of D-
luciferin potassium salt solution i.p. prior to anaesthesia with
isoflurane. For optimal imaging, 1 minute exposures were taken
with medium binning, 20 minutes post luciferin injection. For ex
vivo imaging of the brain, mice were injected with 150 mg/kg of D-
luciferin potassium salt solution. After 10 minutes the mice were
sacrificed by CO2 inhalation. The brains were removed and
soaked in 15 mg/ml D-luciferin potassium salt, dissolved in
warmed RMPI 1640, for a further 10 minutes before being
imaged.
Purification of Toxoplasma lysate antigen
RH tachyzoites where harvested from acutely infected BALB/c
mice, by intra-peritoneal washout and lysate antigen (TLA) was
prepared as described previously [37].
Cytokine ELISA
Spleen cell suspensions from infected mice were prepared as
described previously [24]. For re-stimulation, 26105 cells were
incubated with 5 mg TLA in a total volume of 200 ml for 72 h at
37uC in 5% CO2. Supernatants were then used for IFN-c, IL-5,
IL-6 and IL-10 ELISA, using paired antibodies from BD
Bioscience. Absorbance was the read at 405 nm using a microtitre
plate reader (Spectramax 190, Molecular Devices, USA). Con-
centrations were determined against standard curves for each
cytokine (R&D Systems).
Serum nitric oxide
Serum nitric oxide levels were determined by Griess assay.
Blood was collected by cardiac puncture and cells removed by
Author Summary
Toxoplasma gondii is a protozoan (single cell) parasite that
can be transmitted to humans via infection stages in cat
feces or from eating under-cooked meat containing
parasite cysts. The disease, which infects some 30% of
the world population is a major cause of congenital
infection and abortion and can be fatal in immune
compromised hosts. Control of parasite growth has been
shown to be largely, but not wholly, dependent on the
production of nitric oxide (NO) as a result of the enzymatic
activity of inducible nitric oxide synthase (iNOS) on the
substrate L-arginine. It has been suggested that arginase-1
by depleting the L-arginine store can promote parasite
growth. We have recently shown MAP kinase phosphatase-
2 (MKP-2) to increase iNOS and decrease arginase-1 levels
and mice lacking this gene were found to be more
susceptible to T. gondii. Inhibition of iNOS activity in
genetically intact mice demonstrated it was of paramount
importance in controlling parasite growth. Surprisingly,
however, inhibition of arginase-1 in MKP-22/2 mice
demonstrated arginase-1 was also protective. Significantly
T. gondii cannot make its own arginine and requires this
from the host cell and consequently iNOS and arginase-1
can work together to starve the parasite of this essential
metabolite.
MKP-2 Deletion during Toxoplasma gondii Infection
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centrifugation at 13,000 rpm for 10 minutes. Protein was removed
from the serum by adding ZnSO4 to a final concentration of
15 mg/ml, vortexing thoroughly and centrifuged at 13,000 rpm
for 10 minutes. The supernatant was retained for the Griess assay.
Griess reagent (equal volumes of 2% sulphanilamide in 5% H3PO4
and 0.2% Napthylene diamine HCL in ddH2O) was added to
samples and standards in a 96 well plate and incubated in the dark
for 10 minutes. Absorbance was read at 540 nm and serum nitrite
concentrations were calculated against a standard curve.
In vivo iNOS and Arginase-1 inhibition
To inhibit iNOS and Arginase-I in vivo, mice received
intraperitoneal doses of N (G)-nitro-L-arginine methyl ester
(200 mg/kg, L-NAME, Sigma UK) or Nv-hydroxy-nor-Arginine
(100 mg nor-NOHA, Merck, UK), respectively [38,39]. Treatment
commenced one day prior to infection.
Generation of murine macrophages
Bone marrow derived macrophages were cultured by flushing
the femurs and tibiae of 6 week old MKP-2+/+ or MKP-22/2mice
with DMEM. Cells were then cultured in DMEM containing 20%
heat inactivated FCS, 30% L-cell conditioned medium, 5 mM L-
glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin and
incubated at 376C for 10 days [35]. After this time adherent cells
were harvested and then seeded into either 12 well plates (16106
cells/ml) or black-walled 96 well plates (0.56105).
Macrophage infection with T. gondii
For infection, 56104 bone marrow derived MKP-2+/+ or MKP-
22/2 macrophages were seeded into black-walled 96 well plates in
complete phenol red free RPMI 1640 medium. The cells were
infected with 56104 type II Prugniaud strain T. gondii tachyzoites,
expressing YFP (Donated by Marcus Meissner, University of
Glasgow). Wells were made up to a final volume of 200 ml.
Macrophages were treated with LPS (100 ng/ml), IFN-c (100 U/
ml), 50 mM nor-NOHA or 5 mM L-NAME as appropriate. Levels
of YFP expression were assayed at 24, 48 and 72 h using the
transillumination feature of the IVIS Spectrum (Caliper Life-
science). An excitation wavelength of 500 nm and emission wave
of 540 nm was used. The light data was quantified using Living
Image software (Caliper Lifescience) using the uninfected macro-
phages as background controls.
Flow cytometry
For re-stimulation, 16106 splenocytes were incubated with
5 mg/ml TLA, ionomycin and phorbol-13-myristate-12-acetate
(PMA, Sigma, UK) (0.5 mg/ml and 10 ng/ml, respectively) for 6 h
at 37uC and 5% CO2. After 3 h incubation Brefeldin A (Sigma)
was added for a further 3 h at a final concentration of 10 ng/ml.
Cells were then harvested for staining and incubated with Fc-Block
(5 mg/ml aCD16/CD32, BD Bioscience, 1% mouse serum in
RPMI) for 10 minutes at room temperature, cells were stained for
1 hour at 4uC with aCD3-PerCP, aCD4-APC-H7 (BD Biosci-
ences) and aCD8-Alexa488 (ebioscience). Cells were fixed using
Fix & Perm (Life Technologies) following manufacturer’s instruc-
tions. Intracellular cytokine staining was performed using aTNF-
PE and aIFN-c-APC (eBioscience). A total of 500,000 events per
sample were acquired on a BD FACSCanto and data analysis was
carried out using FlowJo software.
Natural killer or NKT cells from intraperitoneal exudates
(16106) from infected mice were surface stained with aPanNK-
APC and aCD3-PerCP-eFluor710 before fixing and permeabilisa-
tion. Intracellular staining for IFN-c was performed using aIFN-c-
PE or the respective isotype control, rat IgG1,k-PE (all
eBioscience). A total of 200,000 events was recorded and analysed
using Kaluza software (Beckman Coulter). All values were
normalized to their respective isotype control.
Measurement of Arginase-1 expression and activity
Cell lysates (20 mg protein/lane) were separated by 10% SDS-
PAGE and transferred onto a nitrocellulose membrane and
probed for Arginase-1 as previously described [35]. Arginase
activity from murine BMD-macrophages was measured using an
assay based on a reaction with a-isonitrosopropiophenon (ISPF) as
described previously [35].
Preparation of cDNA
Peritoneal exudates from mice were counted and 16106 cells
from each sample taken for RNA extraction using RNeasy Mini
Kit (Qiagen, UK) following manufacturer’s instructions. For each
reaction, 2 mg of total RNA and 300 ng of random primers
(Promega) were incubated at 65uC for 5 minutes. Following a
10 minute incubation at room temperature 2 ml of AffinityScript
reverse transcriptase (RT) buffer (Agilent Technologies), 10 mM
dithiothreitol, 4 mM dNTP mix (Promega) and 1 ml of Affinity-
Script multiple RT (Agilent Technologies) were added to each
sample. These were then incubated for 10 minutes at 25uC,
1 hour at 50uC and 15 minutes at 70uC.
Quantitative real-time PCR (qRT-PCR)
qRT-PCR experiments were conducted on the Stratagene
Mx3000p system (Stratagene, Agilent). Each reaction consisted of
5 ml Brilliant III Ultra-fast SYBR Green QPCR Master Mix
(Agilent Technologies), 3.5 ml of molecular grade water (Life
Technologies), 25 pmol of the forward and reverse primers (Table
S1), and 1 ml of the cDNA template. PCR reactions were carried
out with the following thermoprofile: one cycle at 95uC for
10 minutes, 40 cycles of 20 seconds at 95uC, 20 seconds at 64uC
and 30 seconds at 70uC. Relative gene expression was calculated
based on the DCT for each gene, normalized to that of the
housekeeping gene (TBP).
Statistics
Statistical analysis was performed using GraphPad Prism
Program (Version 5.0, GraphPad Software, California). All results
are shown as standard error of the mean (SEM). Statistically
significant differences were determined using students t-test for
parametric and Mann Whitney U test for non-parametric data,
respectively. P values equal or below 0.05 were considered
significant.
Results
MKP-2 deficiency results in increased susceptibility
following infection with T. gondii
Intraperitoneal infection with 20 cysts of the Beverley (type-II)
strain of T. gondii resulted in significant mortality, typically between
80–100%, 15–25 days post-infection in MKP-22/2, but not
MKP-2+/+ mice (Figure 1A). In order to determine whether this
was associated with any inability of the MKP-22/2mice to control
parasite growth, MKP-22/2 and MKP-2+/+ mice were infected
i.p. with 20,000 type-II strain Prugniaud-FLUC tachyzoites and
parasite burdens measured at 2 day intervals by bioluminescent
imaging (Figure 1B and C). At days 8 (Figure 1B) and 10 the
bioluminescent intensity and consequently parasite burdens were
significantly greater (p,0.031 and p,0.0079 respectively) in
MKP-2 Deletion during Toxoplasma gondii Infection
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MKP-22/2 compared with MKP-2+/+ mice (Figure 1C). Greater
parasite numbers in infected MKP-22/2 as opposed to MKP-2+/+
mice during acute infections were confirmed by qRT-PCR (Figure
S2) The increased susceptibility of MKP-22/2 mice infected with
Prugniaud-FLUC tachyzoites compared with their wild-type
counterparts was also evident during the chronic phase of the
disease: mortality was typically 40–60% in MKP-22/2 mice and
by day 30 post-infection the excised brains of MKP-22/2 mice
were revealed to have significantly higher parasite burdens
(p,0.02) than similarly infected MKP-2+/+ animals (Figure 1D
and E). Increased parasite burdens in infected MKP-22/2
compared with MKP-2+/+ mice were also evident in other tissues
Figure 1. MKP-2 deficiency results in increased susceptibility to T. gondii infection. Mice were infected with 10 Beverley tissue cysts
intraperitoneally and mortality monitored (A). For in vivo bioluminescent imaging and parasite quantification, mice were infected with 20,000 type II
Prugniaud tachyzoites, expressing firefly luciferase. Mice were imaged as outlined in the methods (B). Parasite burdens were determined by
measuring whole body Total Flux (Photons/second) using Living Image 4.0 (C). Each value represents the mean of 5 animals per experimental group
6 SEM. On day 30 post-infection brains were imaged ex vivo as outlined in the methods (D). Chronic parasite burden was determined by measuring
Total Flux (photons/second) from each brain (E). Each value represents the mean of four animals per experimental group 6 SEM. All experiments
were carried out on at least two occasions.
doi:10.1371/journal.ppat.1003535.g001
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at this late stage (Liver: MKP-22/2 4.76610564.76103p/s,
MKP-2+/+ 3.85610564.66104p/s; Kidney: MKP-22/2
1.316106646104p/s, MKP-2+/+ 4.76610561.36105p/s
p,0.05).
MKP-22/2 mice infected with T. gondii do not have an
impaired immune response
In order to determine whether the increased susceptibility of
MKP-22/2 mice infected with T. gondii was the result of an
impaired adaptive immune response spleens were removed and
splenocytes stimulated with TLA at days 10, 20 and 30 post-
infection and IFN-c, IL-4, IL-5 and IL-10 production measured in
the supernatants. There were generally no differences between the
ability of splenocytes from MKP-22/2 or MKP-2+/+ mice infected
with T. gondii to produce cytokines when stimulated with parasite
lysate antigen. This was consistent through both acute and chronic
infection for the primary mediator of parasite control IFN-c
(Figure 2). There was also no difference in the absolute number of
cytokine producing cells between MKP-22/2 and MKP-2+/+ mice
(Figure S3). Flow cytometry analysis (Figure 3) of splenocytes from
MKP-22/2 and MKP-2+/+ mice day 10 post-infection either
under resting conditions, following antigen stimulation, or
following treatment with ionomycin and PMA revealed no
differences in the overall numbers of CD4+ or CD8+ T cells. In
addition no differences in the frequencies of CD4+ (Figure 3B) or
CD8+ (Figure 3C) T cells producing IFN-c, or TNF-a, or both
IFN-c and TNF-a (Figure 3) were noted. In addition, while no
IFN-c was detected in NK cells equivalent amounts of NKT cells
producing IFN-c were detected from both infected MKP-22/2
and MKP-2+/+ mice (Figure S4). Consequently, there was little
evidence that MKP-22/2 mice were limited in their ability to
mount a type-1 response. Furthermore we examined the
expressions of IFN-c dependent GTPases by qRT-PCR and
found these to be comparable in both infected MKP-22/2 and
MKP-2+/+ mice (Figure S2).
MKP-22/2 mice infected with T. gondii have decreased
systemic nitrite levels and increased tissue arginase-1
expression
Serum nitrite levels were significantly higher (p,0.0028) in
MKP-2+/+ mice compared with MKP-22/2 at day 10 post-
infection coincident with the noted inverse differences in T. gondii
parasite burdens between MKP-22/2 and MKP-2+/+ mice
(Figure 4A). Nitrite levels were below the level of detection in
both non-infected MKP-22/2 and MKP-2+/+ mice. At the same
time spleen arginase-I expression was higher in MKP-22/2
compared with MKP-2+/+ mice in both, the uninfected as well as
in the T. gondii infected groups (Figure 4B). Infection with T. gondii
in general increased splenic arginase-I levels in all mice
independent of the genotype (Figure 4B).
Inhibition of NO production by L-NAME enhances the
susceptibility of MKP-2+/+ but not MKP-22/2 mice to T.
gondii infection
In order to determine whether the enhanced NO production by
T. gondii infected MKP-2+/+ mice over their MKP-2 deficient
counterparts was responsible for their increased resistance to
parasite growth and survival in vivo, NO production was inhibited
in infected mice by intraperitoneal injection with the iNOS
inhibitor L-NAME. While L-NAME treatment of infected MKP-
2+/+ mice resulted in 100% mortality by day 10 post-infection,
surprisingly the majority of L-NAME treated infected MKP-22/2
mice survived until day 12 post-infection (Figure 5A). No nitrite
was detectable in L-NAME treated mice. All non-treated infected
MKP-22/2 and MKP-2+/+ mice survived until day 12 (Figure 5A)
and in agreement with previous studies at day 10 there were
significantly more parasites in MKP-22/2 mice (p,0.03).
Measurement of bioluminescence (Figure 5B) allowed quantifica-
tion of parasite burdens and demonstrated a significant increase in
parasite growth at days 6 and 8 post-infection (day 6 p=0.017,
day 8 p=0.005) in L-NAME treated as opposed to non-treated
MKP-2+/+ mice (Figure 5C). By comparison treatment of infected
MKP-22/2 mice with L-NAME did not significantly alter parasite
growth (Figure 5C).
Inhibition of arginase-1 activity by nor-NOHA enhances
the susceptibility of MKP-22/2 but not MKP-2+/+ mice to
T. gondii infection
Unlike their wild-type counterparts, inhibition of NO produc-
tion did not increase parasite growth or the early mortality of
MKP-22/2 mice infected with T.gondii. This implied an alterna-
tive mechanism of controlling early infection in the absence of
MKP-2. As T. gondii is an L-arginine auxotroph [40] we suspected
that over expression of arginase-1 in MKP-22/2 mice could also
Figure 2. MKP-22/2 and MKP-2+/+ splenocyte IFN-c production was similar through the acute and chronic stages of infection.
Splenocytes from T. gondii infected mice were stimulated with TLA (5 mg/ml) and the supernatants assessed for IFN-c by ELISA. Each value represents
the mean of four animals per experimental group 6 SEM. All experiments were carried out on at least two occasions.
doi:10.1371/journal.ppat.1003535.g002
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be playing a protective role. To determine the possibility that
arginase-1 expression might arrest parasite growth through
arginine depletion, infected MKP-22/2 and MKP-2+/+ mice
were treated with the arginase-1 inhibitor nor-NOHA. Nor-
NOHA did not significantly increase mortality in either MKP-22/
2 nor MKP-2+/+ mice infected with T. gondii compared with non-
Figure 3. MKP-2 deletion does not impair T cell responses during infection with T. gondii. T cell responses were determined by flow
cytometry. Cells were surface-stained for CD3, CD4 and CD8 and intracellular for IFN-c and TNF-a. Live cells were gated on forward (FSC) versus side
scatter (SSC). T cells were first gated for CD3 and then sub-gated for either CD4 or CD8 and subsequently their respective antigen-specific intracellular
cytokine production, following stimulation with TLA (10 mg/ml). The specificity of the intracellular staining was ensured by analysing the respective
isotype controls and normalizing samples accordingly (A). Populations of CD3+ CD4+ T cells (B) and CD3+ CD8+ T cells (C) single or double positive for
IFN-c and TNF-a were determined using FlowJo software. Each value represents the mean of four animals per experimental group 6 SEM. All
experiments were carried out on at least two occasions.
doi:10.1371/journal.ppat.1003535.g003
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drug treated controls (Figure 6A). However, measurement of
bioluminescence (Figure 6B) demonstrated significantly greater
(p = 0.02 parasite burden day 8 post-infection in nor-NOHA
treated as opposed to non-treated MKP-22/2 mice (Figure 6C).
This is despite nor-NOHA treatment up-regulating iNOS activity
in MKP-22/2 mice as measured by increased nitrite production
by as much as62. By comparison nor-NOHA treatment had little
effect on parasite burden during early T. gondii infection in MKP-
2+/+ mice (Figure 6C).
MKP-2 deficiency does not render macrophages more
susceptible to infection with T. gondii
We next determined whether the increased susceptibility of
MKP-22/2 mice to infection with T. gondii was a result of their
macrophages being more permissive to parasite growth. MKP-22/
2 and MKP-2+/+ bone marrow derived macrophages were
infected with YFP expressing Prugniaud T. gondii tachyzoites at a
1:1 ratio. In addition the macrophages were either treated with
LPS and IFN-c with or without L-NAME or nor-NOHA. Parasite
growth was then determined by assessing YFP fluorescence. At
24 hours, through to 72 hours post-infection parasite growth was
similar in non-stimulated MKP-22/2 and MKP-2+/+ macrophag-
es (Figure 7A). In addition, following LPS/IFN–c stimulation
parasite growth was significantly, and equally, reduced over the
non-treated macrophages (p = 0.0001) and this was irrespective of
whether the macrophages were derived from MKP-2+/+ or MKP-
22/2 mice (Figure 7A). Treatment of LPS/IFN–c activated MKP-
22/2 and MKP-2+/+ macrophages with L-NAME partially
ablated their ability to control parasite replication at 24 hours
and totally ablated their ability to control parasite growth through
48 hours and 72 hours post-infection (p,0.0001) (Figure 7A).
Conversely, treatment of LPS/IFN-c activated MKP-22/2 and
MKP-2+/+ macrophages with nor-NOHA partially ablated their
ability to control parasite growth at 24 hours (MKP-2+/+ p= 0.005
and MKP-22/2 p= 0.006 respectively) but not at 48 or 72 hours
post-infection (Figure 7A). While LPS/IFN-c activation stimulated
NO production, as measured by nitrite production 72 hours post-
infection in the supernatants of T. gondii infected MKP-22/2 and
MKP-2+/+ macrophages, this was significantly higher in the
infected MKP-2+/+ culture supernatants (p,0.0001) (Figure 7B).
Treatment of LPS/IFN-c activated macrophages with L-NAME,
but not nor-NOHA, largely ablated NO production by both
MKP-22/2 and MKP-2+/+ macrophages (p,0.0001) (Figure 7B).
T. gondii tachyzoite infection was found to enhance macrophage
arginase-1 expression (Figure 8A) although this was consistently
higher in MKP-22/2 than in MKP-2+/+ macrophages up to
24 hours post-infection. Increased expression of arginase-1
following macrophage infection with T. gondii (Figure 8A) was
also reflected in up-regulated enzyme activity at 24 hours post-
infection in both MKP-22/2 (p,0.05) and MKP-2+/+ macro-
phages (Figure 8B). Arginase-1 activity was significantly greater in
MKP-22/2 than in MKP-2+/+ infected macrophages (p,0.001
for non-activated macrophages and p,0.0001 for LPS/IFN–c
activated macrophages) but was effectively and equally inhibited
by nor-NOHA in both MKP-22/2 and MKP-2+/+ macrophages.
Interestingly while L-NAME treatment significantly increased
arginase-1 activity in non-activated MKP-22/2 and MKP-2+/+
macrophages (p,0.02 for both) and LPS/IFN-c activated MKP-
22/2 cultures (p,0.01) this was not noted in activated MKP-2+/+
macrophages (Figure 8B).
Discussion
The present study demonstrates an important role for MKP-2
in controlling infection with T. gondii as infected MKP-22/2
C57BL/6 mice were found to be less able to control parasite
growth during both acute and chronic infection as well as
displaying increased mortality compared with their wild-type
counterparts. The enhanced susceptibility of MKP-22/2 mice was
associated with increased tissue arginase-1 expression, generally
associated with Th2 responses, and at the same time lowered
serum nitrite levels, generally associated with type-1 responses.
Nevertheless, increased susceptibility was not associated with any
significant modifications of the adaptive immune response
between MKP-2 deficient and wild-type mice and the type-1
responses generated in infected MKP-22/2 mice were at least as
strong as in their MKP-2+/+ counterparts. Rather, the recently
identified unique feature of MKP-2 as a negative regulator of
macrophage arginase-1 expression and a positive regulator of
macrophage iNOS expression [35] would appear to underlie the
important role of this member of the dual specific phosphatase
family in controlling infection with T. gondii. While highlighting the
importance of iNOS and NO production in controlling T. gondii
infection, the present study also uncovered a protective role for
arginase-1 in controlling parasite multiplication that can compen-
sate for NO deficiency during early infection.
Generally protective immunity against T. gondii is associated
with a type-1 response where IFN-c synergizes with TNF-a to
activate macrophages and induce the expression of inducible nitric
oxide synthase (iNOS) that catalyzes the formation of nitric oxide
Figure 4. Systemic serum nitrite levels are reduced and tissue
arginase-1 expression is enhanced in MKP-22/2 compared with
MKP-2+/+ mice infected with T. gondii. Serum from infected animals
was assessed for its nitrite content by Griess assay. Each value
represents the mean from ten animals per experimental group 6
SEM (A). Splenocyte cell lysates were prepared and assayed for
Arginase-1 by western blot. Cells were lysed in sample buffer and
protein concentrations measured for each mouse. Equal amounts/
animal were pooled and 20 mg loaded for each lane (B). **P,0.005. All
experiments were carried out on at least two occasions.
doi:10.1371/journal.ppat.1003535.g004
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(NO) from L-Arginine. While NO can directly kill the parasites
[6,10] some studies have also shown that NO promotes tachyzoite
conversion to the much slower dividing bradyzoite form of the
parasite through inhibition of mitochondrial and nuclear enzymes
essential for parasite respiration [41]. Although iNOS seems to be
the predominant pathway used by classically activated macro-
phages to control T. gondii proliferation in tissue culture, the role of
NO during in vivo infection is less clear. Studies using iNOS-
deficient mice have shown that mice lacking iNOS are able to
survive and control tachyzoite growth during the acute stage of
infection via an IFN-c dependent mechanism and only succumb
during chronic toxoplasmosis [42]. Death was associated with
uncontrolled proliferation of tachyzoites in the brain, suggesting
that the protective anti-toxoplasmic effect in the brain was iNOS-
dependent [42,43]. Nevertheless, the observation that iNOS
deficient mice were able to survive acute infection in an IFN-c
mediated manner suggested that there were alternative pathways
other than NO production mediating anti-toxoplasma resistance in
vivo [44]. In addition, a further IFN-c and NO independent
control of T. gondii has been identified in IFN regulatory factor-1
gene deficient mice [45].
In the present study we found that L-NAME treatment of wild-
type mice infected with 20,000 type-II Prugniaud-FLUC
tachyzoites but not MKP-22/2 mice resulted in enhanced
parasite burden and mortality early in infection. This indicated
that an NO independent mechanism was playing a protective role
in MKP-22/2 mice and controlling parasite growth under
conditions where NO generation was being inhibited. Previously
induction of the IFN-c inducible gene IDO has been implicated
in mediating some of the IFN-c dependent NO independent anti-
Toxoplasma activity [11]. IDO catalyzes the degradation of the
essential amino acid L-tryptophan through the kynurenine
pathway, thereby depriving the parasite of this essential amino
acid [12]. Interestingly the relative contributions of iNOS and
IDO to parasite control appear to be tissue specific [12]. More
recently immunity-related GTPases (IRGs) have emerged as
potent effectors of T gondii killing in mice [13,14]. Thus, murine
astrocytes have been shown to have the ability to kill intracellular
T. gondii independently of iNOS and IDO via IFN-c inducible
IRGs [18–20]. Different IRGs have been shown to play roles in
controlling acute and chronic infection [16,17] although the
mechanisms through which p47 GTPases confer resistance to T.
gondii infection have not been determined [21]. However, as no
difference in IFN-c production was noted between infected
MKP-2+/+ and MKP-22/2 mice infected with T. gondii this
would suggest GTPase production was not associated with the
NO independent resistance demonstrated by MKP-22/2 mice.
We have now examined qRT-PCR the expression of the IFN-c
inducible genes LRG47 and IGTPGTPase in infectedMKP-22/2
and MKP-2+/+ mice and indeed found them comparable.
Consequently, this would suggest that an IFN-c independent
mechanism was operating to protect MKP-22/2 mice in the
absence of NO production.
Butcher and colleagues (2011) have recently demonstrated that
the type-1 strain T. gondii parasites deficient in ROP16 have
enhanced growth in macrophages, and in vivo infection results in
increased parasite multiplication and dissemination in the host.
This has been associated with the inability of ROP16 deficient
parasites to induce STAT-6 mediated arginase-1 expression
resulting in maintenance of host cell L-arginine which is exploited
by the parasite. It has previously been demonstrated that T. gondii
is an L-arginine auxotroph [40] and parasite multiplication in the
host cell is L-arginine dependent. Previously studies have
demonstrated that polymorphisms in ROP-16 from type-2
parasites result in their inability or greatly reduced ability to
activate STAT3/6 [46,47]. However, in the course of the present
study these type-2 parasites were shown to increase arginase-1
expression and activity in both MKP-2+/+ and MKP-22/2
macrophages. While often thought of as a Th2 associated product
of alternative macrophage activation, innate macrophage activa-
tion via TLR-4 ligation [48,49] has also been shown to induce
arginase-1 expression. As T gondii has been demonstrated to have a
number of TLR-4 ligands such as GPI anchors [50] and HSP70
[51,52] this is the likely source of the STAT-6 independent
induction of arginase-1 by type-2 strain parasites as demonstrated
in the present study. In vivo treatment with nor-NOHA to inhibit
arginase-1 activity during the course of the present study resulted
in enhanced parasite multiplication in MKP-22/2 mice. This
indicated that the enhanced expression of arginase-1 expression in
these mice could in some part compensate for iNOS deficiency
compared with MKP-2+/+ animals.
Many studies suggest that macrophage killing of parasites via
iNOS catalyzed NO production is the main mechanism by which
T. gondii parasite multiplication is controlled [33,53] and that L-
arginine depletion by arginase-1 counter-regulates the effectiveness
of iNOS and facilitates parasite growth. Our in vitro studies
utilizing classically activated BMDM clearly demonstrate that
iNOS catalyzed NO production plays the major role in controlling
parasite growth and this could be reversed by treatment of cultures
with L-NAME. This was irrespective of whether MKP-22/2 or
MKP-2+/+ macrophages were examined. Interestingly despite
producing less NO than activated MKP-2+/+ macrophages,
activated MKP-22/2 macrophages were equally able to control
parasite growth. Indeed inhibition of arginase-1 activity by nor-
NOHA treatment did not facilitate parasite growth inhibition in
activated MKP-22/2 or MKP-2+/+ macrophages, but in fact
reversed inhibition of parasite growth early under conditions of
activation. This clearly indicates a role for arginase-1 in protection
against T. gondii. Surprisingly no differences in intracellular
parasite growth in MKP-22/2 versus MKP-2+/+ macrophages in
vitro were noted, suggesting the differential weighting of the
alternative control mechanisms were compensating for each other
over the course of the experiment. Nevertheless, the in vivo
consequences of MKP-2 deficiency are significant in terms of
parasite growth and long-term survival, and this would be in
keeping with NO playing a role post-acute infection. It is also likely
that cells other than macrophages are contributing to the
dysregulated iNOS/arginase-1 expression bias in vivo in infected
MKP-22/2 mice. Likely candidates would be neutrophils: these
have previously been shown to play a significant role in early T.
gondii infections [54] and have been shown to be major sources of
arginase-1 activity in vivo and influence the disease process in
humans [55]. This is currently under investigation in the murine
model.
Figure 5. NO inhibition by L-NAME enhances susceptibility of MKP-2+/+ but not MKP-22/2 mice to T. gondii infection. Mice were pre-
treated with L-NAME and subsequently treated with L-NAME (100 mg per mouse) daily following infection with 20,000 Prugniaud tachyzoites
expressing firefly luciferase. Mortality was measured over 12 days (A). Mice were imaged every second day. (B) Represents day 8 post-infection. The
parasite burden was determined by measuring the total flux (photons/second) for each group (C). Each value represents the mean of five mice per
group 6 SEM. *P,0.05. All experiments were carried out on at least two occasions.
doi:10.1371/journal.ppat.1003535.g005
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Figure 6. Arginase-1 inhibition by nor-NOHA enhances susceptibility of MKP-22/2 but not MKP-2+/+ mice to T. gondii infection. Mice
were pre-treated with nor-NOHA (200 mg/kg) and treated daily following infectionwith 20,000 FLUC Prugniaud tachyzoites (A). Mice were imaged every
second day post-infection. (B) Represents day 8 post-infection. Total flux (photons/second) was determined for each animal to determine parasite
burden (C). Each value represents the mean of five mice per group 6 SEM. *P,0.05. All experiments were carried out on at least two occasions.
doi:10.1371/journal.ppat.1003535.g006
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Figure 7.MKP-2 deficientmacrophages display deficient iNOS activity but do not display an increased susceptibility to infection. BMD
macrophages were treated as appropriate with L-NAME, nor-NOHA, LPS and IFN-c and subsequently infected with Prugniaud tachyzoites expressing
YFP. After 24 and 72 h parasite burdens was determined by measuring YFP fluorescence (A). Supernatants from cultures were assayed for nitrite content
by Griess assay (B). Each value represents four replicates 6 SEM. ***P,0.005. All experiments were carried out on at least two occasions.
doi:10.1371/journal.ppat.1003535.g007
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Our studies on the consequences of MKP-2 deficiency have
revealed some fascinating insights into the control of T. gondii
infection. Firstly NO induction is ultimately of paramount
significance in controlling parasite multiplication and host survival.
However, in the absence of NO production enhanced arginase-1 is
able to in part compensate for this deficiency presumably by
starving the parasite of L-arginine as previously demonstrated
[31]. Previously it has been suggested that arginase-1 stimulates
parasite growth by converting L-arginine to the polyamines
needed by the parasite [32] or inhibiting iNOS activity by L-
arginine depletion [33]. We could find no evidence for this. Rather
we would propose that arginase-1 and iNOS work together to
control parasite multiplication by a combination of L-arginine
starvation (arginase-1 and iNOS) and NO killing (iNOS).
Overall our results demonstrate that MKP-2 through its ability
to reciprocally modulate arginase-1 and iNOS expression is a key
regulator in L-arginine metabolism and consequently this has clear
consequences for the control of intracellular parasites. Further-
more as arginase-1 has also been shown to have potent T cell
modulatory effects [55,56] MKP-2 influences are likely to have
significant consequences for inflammatory disease and cancers
where arginase-1 and iNOS have already been identified as key
players [57–59]. These observations identify manipulation of
MKP-2 expression or activity as a significant target for future
therapeutic strategies.
Supporting Information
Figure S1 In vitro assessment of bioluminescence of T.
gondii prior to murine infection and assessment of
optimal in vivo imaging time. Prior to infections being
carried out T. gondii tachyzoites were assessed for their ability to
luminesce (A). This was carried out as a quality control step prior
to every infection. The optimal time to image mice following
luciferin injection (B) was determined. MKP-2+/+ mice infected
with 20,000 FLUC tachyzoites were imaged for 1 minute, every
5 minutes post luciferin injection. A consistent maximum signal
was evident from 15–35 minutes post luciferin injection. 20 min-
utes was therefore chosen for all future experiments.
(TIF)
Figure 8. MKP-2 deficient macrophages display enhanced arginase-1 expression and activity. BMD macrophage cell lysates were
examined for arginase-1 expression following infection (A). BMD macrophages were treated as appropriate with L-NAME, nor-NOHA, LPS and IFN-c
and subsequently infected with Prugniaud tachyzoites expressing YFP (B). At 24 hours post-infection supernatants were assayed for arginase-1
activity as described in Methods. Each value represents four replicates 6 SEM. **P,0.01 ***P,0.005.
doi:10.1371/journal.ppat.1003535.g008
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Figure S2 MKP-22/2 mice have an increased parasite
burden and display no differences in immune regulated
GTPases associated with control of T. gondii infection.
On day 7 post infection, peritoneal exudates from MKP-2+/+ and
MKP-22/2 mice infected with FLUC T. gondii were assessed for
parasite burden by quantitative real-time PCR (qRT-PCR) for
parasitic SAG1 (A) There were no parasites detected by qRT-PCR
in the tissues at this stage but by day 10 post-infection increased
parasite burdens were noted in the tissues including the lungs of
MKP-22/2 mice (B). Splenocytes from infected MKP-2+/+ and
MKP-22/2 were analysed by qRT-PCR for expression of murine
LRG47 and IRGP (C). Each value represents 4 replicates 6SEM.
* P,0.05. Results are from 2 independent experiments
(TIF)
Figure S3 Total numbers of cytokine producing T cells.
Splenocytes from T. gondii infected mice were re-stimulated and
analysed using flow cytometry. Cells were surface-stained for CD3,
CD4 and CD8 and intracellular for IFN-c and TNF-a.
Populations of CD3+ CD4+ T cells (A) and CD3+ CD8+ T cells
(B) single or double positive for IFN-c and TNF-a were
determined and normalized to their respective isotype control.
Total numbers of cytokine producing cells were calculated by
multiplying the percentage value with the total cell number for the
individual spleen. Each bar represents the mean of four animals
per experimental group 6 SEM. All experiments were carried out
on at least two occasions.
(TIF)
Figure S4 Infected MKP-2+/+ and MKP-22/2 mice have
similar numbers of IFN-c producing NKT cells. Intraper-
itoneal exudates from T. gondii infected mice were surface stained
for CD3 and Pan-NK and intracellular for IFN-c and analysed by
flow cytometry. Viable, Pan-NK positive cells were analysed for
the presence of CD3 and distinguished between CD3+, Pan-NK+
(NKT cells) and CD32, Pan-NK+ (NK cells) populations and
values for IFN-c positive cells were normalized to their respective
isotype control. Since NK cells did not produce any IFN-c only
NKT cells are presented. Shown are the %IFN-c+ cells from all
PanNK+ cells (A) and %IFN-c+ NKT cells from the total cell
population (B). Each bar represents the mean of four animals per
experimental group 6 SEM.
(TIF)
Table S1 Primer sequences. Oligonucleotide sequences of
primers used for analysis of gene expression by Real-Time PCR.
(TIF)
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